The Committee on Immunization of Quebec (Comité sur l’immunisation du Québec - CIQ) has recommended use of RSV (respiratory syncytial virus) vaccines, including Arexvy, for the prevention of RSV among older adults at increased risk of severe outcomes from the virus. Specifically, CIQ recommends vaccination for older adults living in residential and long-term care centres (CHSLDs), intermediate resources (RI-SAPA), as well as adults aged 75 and older living in private seniors’ residences and those with chronic illnesses living in the community.
July 25 (Reuters) - There is no doubt that plaintiffs' firms representing nearly 900 clients who claim to have developed cancer after taking the heartburn medication Zantac wanted to litigate their clients’ cases in state court.
Pace Life Sciences, a full-service FDA-registered GMP analytical testing laboratory and contract development and manufacturing organization (CDMO) and a division of Pace, a science and technology company, announced a successful inspection from the Food & Drug Administration (FDA).
Stuart Therapeutics, a clinical-stage ophthalmic biopharmaceutical company focused on developing therapies for the treatment of anterior segment, refractive and posterior segment eye disorders, has added Lukas Scheibler, PhD as its Chief Science and Technology Officer.
The FDA’s Oncologic Drugs Advisory Committee (ODAC) has unanimously called for a revamp of perioperative clinical trial designs in resectable non-small cell lung cancer (NSCLC) to include assessment of the contribution of each treatment phase.
Among AstraZeneca’s growth drivers with $5 billion or more in peak sales potential, the company is counting on Daiichi Sankyo-partnered Enhertu to chart new territory. And stalling sales underscore the challenges facing the HER2 drug.
Edwards Lifesciences is dropping about $1.6 billion on a pair of acquisitions to bolster its structural heart portfolio. nnThey comprise JenaValve Technology, which is developing a transcatheter valve aimed at aortic regurgitation, and Endotronix, the maker of an implantable heart failure monitor.
Abbott is asking users of its FreeStyle Libre 3 diabetes monitors to check the serial numbers of their sensors after the company found that a limited number could provide incorrectly high glucose readings.
AbbVie is discontinuing solo development of a midstage Alzheimer’s disease candidate, a monoclonal antibody that failed to differentiate itself against already approved treatments.